Abstract | PURPOSE OF REVIEW: The prevalence of diabetes mellitus is increasing rapidly worldwide. The number of patients with diabetic nephropathy is also expected to increase considerably in the future despite currently available treatments that may prevent or slow kidney disease progression. Additional therapeutic agents are therefore urgently needed. RECENT FINDINGS: SUMMARY:
|
Authors | Pamela W Anderson, Janet B McGill, Katherine R Tuttle |
Journal | Current opinion in nephrology and hypertension
(Curr Opin Nephrol Hypertens)
Vol. 16
Issue 5
Pg. 397-402
(Sep 2007)
ISSN: 1062-4821 [Print] England |
PMID | 17693752
(Publication Type: Journal Article, Review)
|
Chemical References |
- Indoles
- Maleimides
- ruboxistaurin
- Protein Kinase C
- Protein Kinase C beta
- bisindolylmaleimide
|
Topics |
- Animals
- Clinical Trials as Topic
- Diabetic Nephropathies
(enzymology, therapy)
- Glomerular Filtration Rate
- Humans
- Indoles
(pharmacology)
- Maleimides
(pharmacology)
- Models, Chemical
- Protein Kinase C
(antagonists & inhibitors)
- Protein Kinase C beta
- Treatment Outcome
|